Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Woo

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
JAMA|October 7, 2021
Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021Emily Jane Woo, Adamma Mba-Jonas, Rositsa B Dimova, et al.
Pediatrics|February 3, 2005
Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003Ann W McMahon, John Iskander, Penina Haber, et al.
Journal of Biomedical Informatics|June 22, 2016
A new algorithmic approach for the extraction of temporal associations from clinical narratives with an application to medical product safety surveillance reportsWei Wang, Kory Kreimeyer, Emily Jane Woo, et al.
American Journal of Public Health|July 14, 2004
Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001Emily Jane Woo, Robert Ball, Ann Bostrom, et al.
Vaccine|September 27, 2014
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013Penina Haber, Pedro L Moro, Michael M McNeil, et al.
Vaccine|March 27, 2007
Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005Azra Dobardzic, Hector Izurieta, Emily Jane Woo, et al.
Human Vaccines & Immunotherapeutics|March 28, 2018
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015Elaine R Miller, Paige Lewis, Tom T Shimabukuro, et al.
Pharmacoepidemiology and Drug Safety|September 6, 2022
Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: Reports to the Vaccine Adverse Event Reporting SystemEmily Jane Woo, Adamma Mba-Jonas, Alisha Thomas, et al.
Vaccine|December 4, 2010
Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008Emily Jane Woo, Robert P Wise, David Menschik, et al.
Drug Safety|February 27, 2024
Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS)Pedro L Moro, Carol Ennulat, Hannah Brown, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
JAMA|October 7, 2021
Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021Emily Jane Woo, Adamma Mba-Jonas, Rositsa B Dimova, et al.
Pediatrics|February 3, 2005
Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003Ann W McMahon, John Iskander, Penina Haber, et al.
Journal of Biomedical Informatics|June 22, 2016
A new algorithmic approach for the extraction of temporal associations from clinical narratives with an application to medical product safety surveillance reportsWei Wang, Kory Kreimeyer, Emily Jane Woo, et al.
American Journal of Public Health|July 14, 2004
Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001Emily Jane Woo, Robert Ball, Ann Bostrom, et al.
Vaccine|September 27, 2014
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013Penina Haber, Pedro L Moro, Michael M McNeil, et al.
Vaccine|March 27, 2007
Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005Azra Dobardzic, Hector Izurieta, Emily Jane Woo, et al.
Human Vaccines & Immunotherapeutics|March 28, 2018
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015Elaine R Miller, Paige Lewis, Tom T Shimabukuro, et al.
Pharmacoepidemiology and Drug Safety|September 6, 2022
Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: Reports to the Vaccine Adverse Event Reporting SystemEmily Jane Woo, Adamma Mba-Jonas, Alisha Thomas, et al.
Vaccine|December 4, 2010
Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008Emily Jane Woo, Robert P Wise, David Menschik, et al.
Drug Safety|February 27, 2024
Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS)Pedro L Moro, Carol Ennulat, Hannah Brown, et al.
Pageof 6